We believe that this knowledge will be key to (i) understand the molecular mechanisms mediating the multiple actions of PI3K and (ii) define specific potential targets for pathological alterations of the PI3K/PTEN pathway, in cases such as autism, schizophrenia, or different forms of intellectual disability (6, 50–53). This evidence concerns the gene PTEN and autism.